Oculogenex is a cutting-edge biopharmaceutical company based in La Habra, California, specializing in gene therapy for retinal disorders. Founded in 2020, they are dedicated to pioneering innovative treatments to improve vision and transform the lives of patients worldwide.
National Ranking28475th
in United States Regional Ranking31095th
in North America Global Ranking74454th
worldwide Rankings by